Securities,
Mergers & Acquisitions,
Corporate,
Civil Litigation
Oct. 21, 2021
Bayer investors’ securities class action over Monsanto merger proceeds
U.S. District Judge Richard Seeborg pointed to massive trial verdicts and a rejected settlement proposal as evidence that Bayer may have lied to investors about the upside of the acquisition. "Deception concerning mismanagement" and "misleading statements concerning due diligence" are grounds for a lawsuit he concluded in his ruling.
Investors suing Bayer secured approval from a federal judge to proceed with a securities class action accusing the German pharmaceutical and chemical maker of deceiving them about properly analyzing the risks of acquiring Monsanto in a multibillion- dollar deal.
Bayer in a statement defended its merger with Monsanto.
U.S. District Judge Richard Seebo...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation, California Supreme Court
State Supreme Court denies review of $86.7M Roundup verdict
By Craig Anderson
U.S. Supreme Court, Torts/Personal Injury, Alternative Dispute Resolution
‘Encouraged’ Bayer suspends weedkiller settlement talks
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Bayer wins case over weedkiller
By Henrik Nilsson
Civil Litigation, California Courts of Appeal
Split circuit panel OKs $87.5M verdict against Monsanto
By Craig Anderson
Civil Litigation
Federal judge issues scathing rebuke of MDL fee ‘holdbacks’
By Gina Kim
Health Care & Hospital Law, Civil Litigation
US judge rejects $2B Roundup deal, cites 'glaring flaws'
By Winston Cho
